Red blood cell substitutes

Area of Science:

• Veterinary Medicine
• Biomedical Engineering
• Hematology

Background:

• Homologous blood transfusions face challenges with supply and safety risks.
• Hemoglobin solutions have emerged as a primary focus for developing red blood cell substitutes.
• Addressing the limitations of traditional blood transfusions is crucial for advancing veterinary care.

Purpose of the Study:

• To explore the development and clinical applications of red blood cell substitutes in veterinary medicine.
• To highlight the potential of hemoglobin-based oxygen carriers (HBOCs) as transfusion alternatives.
• To identify key indications for the use of artificial oxygen carriers in animal health.

Main Methods:

• Review of recent advancements in red blood cell substitute technology.
• Analysis of clinical scenarios where blood transfusions are currently used in veterinary practice.
• Evaluation of hemoglobin solutions as a viable alternative for oxygen delivery.

Main Results:

• Hemoglobin solutions represent a promising area for red blood cell substitute development.
• Potential applications include managing blood loss from trauma, surgery, and medical conditions.
• Adjunctive roles in chemotherapy and radiation therapy are also identified.

Conclusions:

• Red blood cell substitutes, particularly those based on hemoglobin, offer a viable alternative to homologous blood transfusions in veterinary medicine.
• These substitutes address critical needs in managing anemia and acute blood loss.
• Further research and clinical trials are warranted to fully establish their efficacy and safety profile.